Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Name: Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Published: 2021
License: Public Domain

National Cancer Institute (NCI) · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

advanced breast carcinoma, advanced colon carcinoma, advanced colorectal carcinoma, advanced endometrial carcinoma, advanced gastric carcinoma, advanced gastroesophageal junction adenocarcinoma, advanced malignant solid neoplasm, advanced salivary gland carcinoma, anatomic stage iii breast cancer ajcc v8, anatomic stage iv breast cancer ajcc v8, clinical stage iii gastric cancer ajcc v8, clinical stage iii gastroesophageal junction adenocarcinoma ajcc v8

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 829862
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.